Lee Wisner

704 total citations
21 papers, 544 citations indexed

About

Lee Wisner is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Lee Wisner has authored 21 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Lee Wisner's work include Molecular Biology Techniques and Applications (5 papers), Viral-associated cancers and disorders (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Lee Wisner is often cited by papers focused on Molecular Biology Techniques and Applications (5 papers), Viral-associated cancers and disorders (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Lee Wisner collaborates with scholars based in United States, Netherlands and South Africa. Lee Wisner's co-authors include Brian W. Simons, Rachel Swart, Marilena V. Iorio, Christopher Riley, Kishore Shakalya, Daruka Mahadevan, Laurence Cooke, Kimiko Della Croce, Harinder S. Garewal and Raymond B. Nagle and has published in prestigious journals such as Blood, Oncogene and International Journal of Cancer.

In The Last Decade

Lee Wisner

19 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lee Wisner United States 8 216 194 117 88 86 21 544
Melinda S. Gordon United States 10 394 1.8× 195 1.0× 155 1.3× 76 0.9× 251 2.9× 25 683
Petranel T. Ferrão Australia 6 336 1.6× 206 1.1× 203 1.7× 60 0.7× 51 0.6× 8 629
S. Öhl Germany 13 216 1.0× 234 1.2× 179 1.5× 106 1.2× 114 1.3× 19 778
Chiao‐Ying Lin Taiwan 12 444 2.1× 414 2.1× 56 0.5× 88 1.0× 121 1.4× 16 864
Jennifer A. Grabowsky United States 12 389 1.8× 274 1.4× 67 0.6× 104 1.2× 75 0.9× 29 634
Dan Lu China 9 458 2.1× 203 1.0× 76 0.6× 85 1.0× 131 1.5× 16 694
Tetsuji Sawada Japan 20 494 2.3× 392 2.0× 220 1.9× 138 1.6× 199 2.3× 38 928
Laurence Cooke United States 19 532 2.5× 505 2.6× 215 1.8× 207 2.4× 105 1.2× 39 1.1k
Jiabo Di China 15 286 1.3× 237 1.2× 70 0.6× 132 1.5× 168 2.0× 39 578
Daniel Vodák Norway 13 332 1.5× 159 0.8× 104 0.9× 120 1.4× 194 2.3× 23 584

Countries citing papers authored by Lee Wisner

Since Specialization
Citations

This map shows the geographic impact of Lee Wisner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Wisner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Wisner more than expected).

Fields of papers citing papers by Lee Wisner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee Wisner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Wisner. The network helps show where Lee Wisner may publish in the future.

Co-authorship network of co-authors of Lee Wisner

This figure shows the co-authorship network connecting the top 25 collaborators of Lee Wisner. A scholar is included among the top collaborators of Lee Wisner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee Wisner. Lee Wisner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wisner, Lee, Brandon T. Larsen, & Andrew Maguire. (2022). Enhancing Tumor Content through Tumor Macrodissection. Journal of Visualized Experiments. 1 indexed citations
3.
Wisner, Lee, Brandon T. Larsen, & Andrew Maguire. (2022). Manual Construction of a Tissue Microarray using the Tape Method and a Handheld Microarrayer. Journal of Visualized Experiments. 2 indexed citations
4.
Wisner, Lee, et al.. (2022). Enhancing Tumor Content through Tumor Macrodissection. Journal of Visualized Experiments. 1 indexed citations
5.
Schmelz, Monika, et al.. (2021). A Plan for Emergency Shutdown and Reopening for a Consortium of Biobanks. Biopreservation and Biobanking. 19(5). 394–398. 3 indexed citations
6.
Wisner, Lee, Katie R. Zellner, Betty Glinsmann‐Gibson, et al.. (2021). Assessment of 2-Year Storage Conditions on Protein, RNA, and DNA in Unstained Human Tissue Sections, Including a Novel Multiplex Digital Gene Expression Profiling Method with Implications for Biobanking. Biopreservation and Biobanking. 20(6). 473–484. 3 indexed citations
8.
Maguire, Andrew, Lee Wisner, Samantha Kendrick, et al.. (2019). REDUCED BCL2 EXPRESSION SUGGESTS ALTERNATIVE SURVIVAL MECHANISMS IN HIV(+) DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) OF GERMINAL CENTER ORIGIN. Hematological Oncology. 37(S2). 198–198. 2 indexed citations
9.
Glinsmann‐Gibson, Betty, Lee Wisner, Melissa Stanton, et al.. (2019). Recommendations for Tissue Microarray Construction and Quality Assurance. Applied immunohistochemistry & molecular morphology. 28(4). 325–330. 13 indexed citations
10.
Maguire, Andrew, Xianfeng Chen, Lee Wisner, et al.. (2019). Enhanced DNA repair and genomic stability identify a novel HIV‐related diffuse large B‐cell lymphoma signature. International Journal of Cancer. 145(11). 3078–3088. 20 indexed citations
11.
Maguire, Andrew, Gary B. Fogel, Samantha Kendrick, et al.. (2017). Human Immunodeficiency Virus (HIV) Status Drives Diffuse Large B Cell Lymphoma through Oncogenic Signaling Pathways. Blood. 130(Suppl_1). 5128–5128.
12.
Samulitis, Betty K., Anne E. Cress, Hitendra Patel, et al.. (2014). Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors. Cancer Biology & Therapy. 16(1). 43–51. 54 indexed citations
13.
Chang, Hui Hua, et al.. (2011). Identification of a novel class of anti-inflammatory compounds with anti-tumor activity in colorectal and lung cancers. Investigational New Drugs. 30(5). 1865–1877. 11 indexed citations
14.
Dorr, Robert T., Lee Wisner, Betty K. Samulitis, Terry H. Landowski, & William A. Remers. (2011). Anti-tumor activity and mechanism of action for a cyanoaziridine-derivative, AMP423. Cancer Chemotherapy and Pharmacology. 69(4). 1039–1049. 10 indexed citations
15.
Samulitis, Betty K., et al.. (2010). Imexon enhances gemcitabine cytotoxicity by inhibition of ribonucleotide reductase. Cancer Chemotherapy and Pharmacology. 67(1). 183–192. 6 indexed citations
16.
Mahadevan, Daruka, Laurence Cooke, Christopher Riley, et al.. (2007). A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors. Oncogene. 26(27). 3909–3919. 224 indexed citations
17.
Hazlehurst, Lori, Nikola Valkov, Lee Wisner, et al.. (2001). Reduction in drug-induced DNA double-strand breaks associated with β1 integrin–mediated adhesion correlates with drug resistance in U937 cells. Blood. 98(6). 1897–1903. 105 indexed citations
18.
Taetle, Raymond, Mikel Aickin, Jinming Yang, et al.. (1999). Chromosome abnormalities in ovarian adenocarcinoma: I. nonrandom chromosome abnormalities from 244 cases. Genes Chromosomes and Cancer. 25(3). 290–300. 2 indexed citations
19.
Taetle, Raymond, Mikel Aickin, Jinming Yang, et al.. (1999). Chromosome abnormalities in ovarian adenocarcinoma: I. nonrandom chromosome abnormalities from 244 cases. Genes Chromosomes and Cancer. 25(3). 290–300. 70 indexed citations
20.
Cochran, David L., et al.. (1990). The induction of specific metabolic alterations in mouse calvarial organ cultures by glycosaminoglycans. Archives of Oral Biology. 35(7). 515–522. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026